Translating tolerogenic therapies to the clinic - where do we stand?
Manipulation of the immune system to prevent the development of a specific immune response is an ideal strategy to improve outcomes after transplantation. A number of experimental techniques exploiting central and peripheral tolerance mechanisms have demonstrated success, leading to the first early...
Hoofdauteurs: | Issa, F, Wood, K |
---|---|
Formaat: | Journal article |
Taal: | English |
Gepubliceerd in: |
2012
|
Gelijkaardige items
-
Translating Tolerogenic Therapies to the Clinic - Where Do We Stand and What are the Barriers?
door: Cobbold, S, et al.
Gepubliceerd in: (2012) -
Translating tolerogenic therapies to the clinic – where do we stand and what are the barriers?
door: Stephen Paul Cobbold, et al.
Gepubliceerd in: (2012-10-01) -
Tolerogenic Dendritic Cells in Solid Organ Transplantation: Where Do We Stand?
door: Eros Marín, et al.
Gepubliceerd in: (2018-02-01) -
Clinical Microbiology: where do we stand?
door: Alkiviadis Vatopoulos
Gepubliceerd in: (2024-06-01) -
Gene therapy for clinical transplantation: where do we stand in 2006?
door: Tan, P, et al.
Gepubliceerd in: (2006)